Concepedia

Shuli Zhang

SZ

Statistics

Publications

45

Citations

2K

H-Index

24

Active since

1989

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Walther Cancer Foundation

Indiana University – Purdue University Indianapolis

Indiana University School of Medicine

Chinese Academy of Sciences

Shuli Zhang is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in life sciences, molecular biology, and immunology.

ORCID

Publications per year

1989–2024

45

Publications

45

Molecular Mechanisms of CD200 Inhibition of Mast Cell Activation

Shuli Zhang, Holly Cherwinski, Jonathon D. Sedgwick et al. · The Journal of Immunology · 2004 · 241 citations · Full text

, , +17

Essential Role of Signal Transducer and Activator of Transcription (Stat)5a but Not Stat5b for Flt3-Dependent Signaling

Shuli Zhang, Seiji Fukuda, Younghee Lee et al. · The Journal of Experimental Medicine · 2000 · 205 citations · Full text

, , +16

The CD200 Receptor Is a Novel and Potent Regulator of Murine and Human Mast Cell Function

Holly Cherwinski, Craig A. Murphy, Barbara Joyce et al. · The Journal of Immunology · 2005 · 119 citations · Full text

, , +17

Flt3 signaling involves tyrosyl-phosphorylation of SHP-2 and SHIP and their association with Grb2 and Shc in Baf3/Flt3 cells

Shuli Zhang, Charlie Mantel, Hal E. Broxmeyer · Journal of Leukocyte Biology · 1999 · 115 citations

, , +16

Flt3 Ligand Induces Tyrosine Phosphorylation of Gab1 and Gab2 and Their Association with Shp-2, Grb2, and PI3 Kinase

Shuli Zhang, Hal E. Broxmeyer · Biochemical and Biophysical Research Communications · 2000 · 115 citations

, , +14

1–5 of 45